This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 18 and 50
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

This is a prospective, single arm, single intervention safety and immunogenicity study in 6 healthy, malaria-naive adults, conducted to demonstrate the successful implementation of the well-established malaria challenge model at the Seattle Biomedical Research Institute (Seattle BioMed).

Provided treatments

  • Biological: Malaria challenge (wild-type NF54 strain Plasmodium falciparum sporozoites)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01058226. The sponsor of the trial is Seattle Children’s Research Institute (SCRI) and it is looking for 6 volunteers for the current phase.
Official trial title:
Reproducibility of Malaria Challenge in Healthy Volunteers